Atlas Trials

Major Depressive Disorder

1,731 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Major Depressive Disorder

RecordFirmDate
NeuroStar TMS Therapy System: Utilization and Outcomes (NCT01114477)Neuronetics2010-03-01
Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) (NCT01056289)Pfizer2010-03-01
Prevention of Weight Gain in Early Psychoses (NCT01075295)Centre for Addiction and Mental Health2010-02-01
Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial (NCT01070134)Psychiatry Roskilde2010-02-01
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression (NCT01814085)Xian-Janssen Pharmaceutical Ltd.2010-02-01
Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans (NCT00993629)US Department of Veterans Affairs2010-01-01
A Study of the Neurobiology of Depression (NCT01051466)Eli Lilly and Company2010-01-01
Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study (NCT01162382)Washington University School of Medicine2010-01-01
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms (NCT01919216)New York State Psychiatric Institute2010-01-01
Safety Study of F2695 SR in Major Depressive Disorder (NCT01034267)Forest Laboratories2009-12-01
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression (NCT01922219)New York State Psychiatric Institute2009-12-01
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder (NCT01034462)Forest Laboratories2009-12-01
PET Biomarkers in Treatment Resistant Depression (NCT01031810)New York State Psychiatric Institute2009-11-01
AZD7268 Safety and Tolerability Study (NCT01020799)AstraZeneca2009-11-01
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms (NCT01000805)Eli Lilly and Company2009-11-01
The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems? (NCT00988663)Jerrry L Lewis2009-11-01
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder (NCT00985725)Shire2009-10-29
A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care (NCT00939250)University of Texas Southwestern Medical Center2009-10-01
rTMS for Adolescents and Young Adults (NCT00984087)Johns Hopkins University2009-10-01
Neurocognitive Enhancement in Major Depressive Disorder (NCT00998569)Queen's University2009-10-01
Electroencephalography (EEG) Signal Processing (NCT01369290)St. Joseph's Healthcare Hamilton2009-10-01
Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting (NCT02479464)Mayo Clinic2009-10-01
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study (NCT01269710)University of North Carolina, Chapel Hill2009-10-01
Biomarkers for Outcomes In Late-life Depression (BOLD) (NCT01082237)University of California, Los Angeles2009-10-01
Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response (NCT00963196)University of Virginia2009-09-01
A Study of Patients With Major Depressive Disorder and Residual Apathy (NCT00985504)Eli Lilly and Company2009-09-01
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder (NCT00927173)Brainsway2009-09-01
Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder (NCT01221935)Pfizer2009-09-01
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder (NCT00969709)Forest Laboratories2009-09-01
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder (NCT00969150)Forest Laboratories2009-09-01
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder (NCT01447576)Otsuka Pharmaceutical Development & Commercialization, Inc.2009-09-01
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study (NCT00871299)University of California, San Francisco2009-09-01
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat (NCT01971203)Icahn School of Medicine at Mount Sinai2009-09-01
Study of Mindfulness-Based Cognitive Therapy (NCT00943033)Binghamton University2009-08-01
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis (NCT01001559)Pamlab, Inc.2009-08-01
Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant (NCT00905424)Shire2009-07-30
CID 0911 - Adaptation of A Depression Treatment Intervention for HIV Patients in Cameroon (NCT02156622)University of North Carolina, Chapel Hill2009-07-01
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder (NCT00854100)Forest Laboratories2009-06-30
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder (NCT00887224)Pfizer2009-06-01
Slow-wave Sleep Deprivation in Depression (NCT01189591)University of Wisconsin, Madison2009-06-01
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women (NCT00888862)Hamilton Health Sciences Corporation2009-06-01
Duloxetine for Major Depression in Peri-/Postmenopausal Women (NCT00889369)Hamilton Health Sciences Corporation2009-05-01
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression (NCT00953745)Washington University School of Medicine2009-05-01
Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients (NCT00885222)Hadassah Medical Organization2009-05-01
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder (NCT00797966)Otsuka Pharmaceutical Development & Commercialization, Inc.2009-05-01
Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients (NCT00926835)Ministry of Health & Welfare, Korea2009-05-01
Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder (NCT00878748)Wyeth is now a wholly owned subsidiary of Pfizer2009-04-01
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram (NCT00851006)University of Utah2009-04-01
N-methylglycine (Sarcosine) Treatment for Depression (NCT00977353)China Medical University Hospital2009-04-01
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder (NCT00863798)Wyeth is now a wholly owned subsidiary of Pfizer2009-04-01
Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression (NCT00869765)The University of New South Wales2009-04-01
Comparison of Vitamin B12 Supplementation to Selective Serotonin Reuptake Inhibitor (SSRI) Versus SSRI Antidepressant Treatment Alone (NCT00939718)Aga Khan University2009-04-01
Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression (NCT00818506)University of Aarhus2009-03-01
Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD) (NCT00831415)Pfizer2009-03-01
Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder (NCT01541475)Ewha Womans University2009-03-01
Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder (NCT00882362)Otsuka Pharmaceutical Co., Ltd.2009-03-01
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder (NCT00849901)Eli Lilly and Company2009-03-01
Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder (NCT00876343)Otsuka Pharmaceutical Co., Ltd.2009-03-01
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder (NCT00849693)Eli Lilly and Company2009-03-01
Effect of Curcumin as Nutraceutical in Patients of Depression (NCT01022632)Government Medical College, Bhavnagar2009-03-01
Using a Text-message System to Engage Depressed Adolescents in Cognitive-behavioral Therapy Homework (NCT00919932)University of Pittsburgh2009-02-01
Pilot Study of Behavioral Activation for Prolonged Grief (NCT01556048)Anthony Papa2009-02-01
The Efficacy of Parent Involvement in the Treatment of Adolescent Depression (NCT00883519)New York State Psychiatric Institute2009-01-01
Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients (NCT00811252)H. Lundbeck A/S2009-01-01
Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT) (NCT00870805)The University of New South Wales2009-01-01
An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (NCT00822744)Sanofi2008-12-01
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder (NCT00798707)Pfizer2008-12-01
Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression (NCT02132286)University of Calgary2008-12-01
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) (NCT00788918)Aarhus University Hospital2008-11-01
Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder (NCT00807248)H. Lundbeck A/S2008-11-01
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients (NCT00789854)AstraZeneca2008-11-01
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder (NCT00810069)Eli Lilly and Company2008-11-01
General Practice Research Database Seroquel XR Safety Study (NCT01447082)AstraZeneca2008-10-01
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD (NCT00785434)Community Pharmacology Services Ltd2008-10-01
AZD6765 Severe Major Depressive Disorder (MDD) IV (NCT00781742)AstraZeneca2008-10-01
Antidepressant Incomplete Response Depression (NCT00782964)AstraZeneca2008-10-01
Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder (NCT00766870)H. Lundbeck A/S2008-09-01
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy (NCT00683852)Massachusetts General Hospital2008-09-01
Internet-Based Depression Screening for College Students (NCT01326793)Massachusetts General Hospital2008-09-01
Combining Emotion Regulation and Mindfulness Skills for Preventing Depression Relapse (NCT02747134)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2008-09-01
A Study of CX157 (TriRima) for the Treatment of Depression (NCT00739908)CeNeRx BioPharma Inc.2008-09-01
International Study to Predict Optimised Treatment - in Depression (NCT00693849)BRC Operations Pty. Ltd.2008-09-01
Linköping University Relational and Interpersonal Psychotherapy Project (NCT00763594)Linkoeping University2008-09-01
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels (NCT01385709)Weill Medical College of Cornell University2008-08-01
Neural Correlates of Psychodynamic Psychotherapy for Depression (NCT00812227)Massachusetts General Hospital2008-08-01
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics (NCT00742573)New York State Psychiatric Institute2008-08-01
Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder (NCT00735709)Takeda2008-08-01
Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients (NCT00998959)Trina E. Chang, MD2008-08-01
Creatine Augmentation Treatment in Major Depressive Disorder Subjects (NCT00729755)Ewha Womans University2008-08-01
Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs (NCT00633399)Massachusetts General Hospital2008-07-01
Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD) (NCT00731653)Massachusetts General Hospital2008-07-01
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression (NCT00824044)Massachusetts General Hospital2008-07-01
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder (NCT01515215)Centre for Addiction and Mental Health2008-07-01
Cysteamine Therapy for Major Depressive Disorder (NCT00715559)Icahn School of Medicine at Mount Sinai2008-07-01
Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder (NCT01454635)Showa University2008-06-01
Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder (NCT00707980)Takeda2008-06-01
Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder (NCT00868374)Keming Gao2008-06-01
Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode (NCT00807105)Shalvata Mental Health Center2008-06-01
Validating PROMIS Instruments in Depression (NCT00784199)University of Pittsburgh2008-06-01
Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression (NCT00787501)University of Pittsburgh2008-06-01
← Previous Next →

Track Major Depressive Disorder automatically

Every clearance here is in the API, with alerts when new ones post.